NORTHWEST PIPELINE LLC
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
WMB$67.46+1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at December 31, 2025 and 2024
Consolidated Balance Sheet
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| (Millions, except per-share amounts) | ||
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $63 | $60 |
| Trade accounts and other receivables (net of allowance of ($1) at December 31, 2025 and December 31, 2024) | 2,084 | 1,863 |
| Inventories | 314 | 279 |
| Assets held for sale (Note 3) | 318 | 1 |
| Derivative assets | 209 | 267 |
| Other current assets and deferred charges | 256 | 191 |
| Total current assets | 3,244 | 2,661 |
| Investments | 4,559 | 4,140 |
| Property, plant, and equipment – net | 41,996 | 38,692 |
| Intangible assets – net | 6,763 | 7,209 |
| Regulatory assets, deferred charges, and other | 2,011 | 1,830 |
| Total assets | $58,573 | $54,532 |
| LIABILITIES AND EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $2,224 | $1,613 |
| Liabilities held for sale (Note 3) | 63 | — |
| Derivative liabilities | 135 | 164 |
| Other current liabilities | 1,639 | 1,360 |
| Commercial paper | 700 | 455 |
| Long-term debt due within one year | 1,345 | 1,720 |
| Total current liabilities | 6,106 | 5,312 |
| Long-term debt | 27,316 | 24,736 |
| Deferred income tax liabilities | 5,170 | 4,376 |
| Regulatory liabilities, deferred income, and other | 4,986 | 5,268 |
| Contingent liabilities and commitments (Note 18) | ||
| Equity: | ||
| Stockholders’ equity: | ||
| Preferred stock ($1 par value; 30 million shares authorized at December 31, 2025 and December 31, 2024; 35 thousand shares issued at December 31, 2025 and December 31, 2024) | 35 | 35 |
| Common stock ($1 par value; 1,470 million shares authorized at December 31, 2025 and December 31, 2024; 1,261 million shares issued at December 31, 2025 and 1,258 million shares issued at December 31, 2024) | 1,261 | 1,258 |
| Capital in excess of par value | 24,801 | 24,643 |
| Retained deficit | (12,237) | (12,396) |
| Accumulated other comprehensive income (loss) | 127 | 76 |
| Treasury stock, at cost (39 million shares at December 31, 2025 and December 31, 2024 of common stock) | (1,180) | (1,180) |
| Total stockholders’ equity | 12,807 | 12,436 |
| Noncontrolling interests in consolidated subsidiaries | 2,188 | 2,404 |
| Total equity | 14,995 | 14,840 |
| Total liabilities and equity | $58,573 | $54,532 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.